A business in context

RGNX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-10-14 · 0001193125-26-423376 · Items 5.02

  2. 8-K · Current report

    Report date 2026-09-23 · 0001193125-26-399377 · Items 1.01

  3. 4 · Ownership change

    Report date 2026-09-01 · 0002062007-26-000005

  4. 4 · Ownership change

    Report date 2026-09-01 · 0001789335-26-000008

  5. 4 · Ownership change

    Report date 2026-08-25 · 0002023732-26-000008

  6. 8-K · Current report

    Report date 2026-08-25 · 0001193125-26-365287 · Items 5.02,9.01

  7. 8-K · Current report

    Report date 2026-08-24 · 0001193125-26-363786 · Items 7.01,8.01,9.01

  8. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-336725

  9. 8-K · Current report

    Report date 2026-08-06 · 0001193125-26-336716 · Items 2.02,9.01

  10. 4 · Ownership change

    Report date 2026-08-01 · 0001700659-26-000016

  11. 4 · Ownership change

    Report date 2026-08-01 · 0001521123-26-000008

  12. 8-K · Current report

    Report date 2026-07-16 · 0001193125-26-308342 · Items 8.01,9.01

  13. 4 · Ownership change

    Report date 2026-07-02 · 0001700659-26-000014

  14. 4 · Ownership change

    Report date 2025-12-31 · 0001346164-26-000006

  15. 4 · Ownership change

    Report date 2026-06-29 · 0001700659-26-000012

  16. 8-K · Current report

    Report date 2026-06-23 · 0001193125-26-286825 · Items 8.01,9.01

  17. 8-K · Current report

    Report date 2026-05-29 · 0001193125-26-254590 · Items 5.07,8.01

  18. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-222804

  19. 8-K · Current report

    Report date 2026-05-14 · 0001193125-26-222768 · Items 2.02,7.01,8.01,9.01

  20. DEF 14A · Proxy statement

    Report date 2026-05-29 · 0001193125-26-155058

  21. 8-K · Current report

    Report date 2026-03-18 · 0001193125-26-117913 · Items 1.01

  22. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-094013

  23. 8-K · Current report

    Report date 2026-03-05 · 0001193125-26-092566 · Items 2.02,9.01

  24. 8-K · Current report

    Report date 2026-02-07 · 0001193125-26-043342 · Items 7.01,8.01,9.01

  25. 8-K · Current report

    Report date 2026-01-23 · 0001193125-26-026139 · Items 8.01,9.01

  26. 8-K · Current report

    Report date 2025-11-06 · 0001193125-25-268101 · Items 2.02,9.01

  27. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-268095

  28. 8-K · Current report

    Report date 2025-08-18 · 0000950170-25-109829 · Items 8.01,9.01

  29. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001193125-25-174953

  30. 8-K · Current report

    Report date 2025-08-05 · 0001193125-25-174947 · Items 1.01,2.02,7.01,9.01

  31. 8-K · Current report

    Report date 2025-05-30 · 0000950170-25-080986 · Items 5.07

  32. 8-K · Current report

    Report date 2025-05-16 · 0001193125-25-122456 · Items 1.01,2.03,7.01,9.01

  33. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-069237

  34. 8-K · Current report

    Report date 2025-05-12 · 0000950170-25-069211 · Items 2.02,9.01

  35. DEF 14A · Proxy statement

    Report date 2025-05-30 · 0000950170-25-052069

  36. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-038770

  37. 8-K · Current report

    Report date 2025-03-13 · 0000950170-25-038711 · Items 2.02,9.01

  38. 8-K · Current report

    Report date 2025-03-03 · 0001193125-25-045585 · Items 7.01,8.01,9.01

  39. 8-K · Current report

    Report date 2025-01-14 · 0001193125-25-005659 · Items 1.01,7.01,9.01

  40. 8-K · Current report

    Report date 2024-12-09 · 0001193125-24-273467 · Items 8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 2 transaction rows2PSale: 3 transaction rows3SGrant / award: 4 transaction rows4AExercise / conversion: 4 transaction rows4MTax / exercise payment: 5 transaction rows5FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

18 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-01
2026-09-03
Malzahn CraigF · Tax / exercise payment
Disposed
Common Stock234.09.32
2026-09-01
2026-09-03
Chan MitchellF · Tax / exercise payment
Disposed
Common Stock4902.09.32
2026-08-27
2026-08-27
Ciongoli Gregory AustinP · Purchase
Acquired
Common Stock53407.09.36
2026-08-26
2026-08-27
Ciongoli Gregory AustinP · Purchase
Acquired
Common Stock49196.09.14
2026-08-25
2026-08-27
Ciongoli Gregory AustinA · Grant / award
Acquired
Common Stock15432.00.0
2026-08-25
2026-08-27
Ciongoli Gregory AustinA · Grant / award
Acquired
Stock Options (Right to buy)
Derivative security
69609.00.0
2026-08-01
2026-08-04
PAKOLA STEVEF · Tax / exercise payment
Disposed
Common Stock7468.09.69
2026-08-01
2026-08-04
Christmas Patrick J.F · Tax / exercise payment
Disposed
Common Stock4699.09.69
2026-07-02
2026-07-06
PAKOLA STEVES · Sale
Disposed
Common Stock2161.013.64
2026-07-02
2026-07-06
PAKOLA STEVEM · Exercise / conversion
Acquired
Common Stock2161.07.86
2026-07-02
2026-07-06
PAKOLA STEVEM · Exercise / conversion
Disposed
Stock Options (Right to Buy)
Derivative security
2161.00.0
2026-07-01
2026-07-01
PAKOLA STEVES · Sale
Disposed
Common Stock36725.012.86
2026-07-01
2026-07-01
PAKOLA STEVEM · Exercise / conversion
Acquired
Common Stock36725.07.86
2026-07-01
2026-07-01
PAKOLA STEVEM · Exercise / conversion
Disposed
Stock Options (Right to Buy)
Derivative security
36725.00.0
2026-07-01
2026-07-06
Simpson CurranF · Tax / exercise payment
Disposed
Common Stock6818.013.09
2026-06-30
2026-07-06
Simpson CurranA · Grant / award
Acquired
Common Stock1453.010.18
2026-06-29
2026-07-01
PAKOLA STEVES · Sale
Disposed
Common Stock19608.011.04
2025-12-31
2026-07-06
Simpson CurranA · Grant / award
Acquired
Common Stock951.07.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001590877REGENXBIO Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • ReGenX Biosciences, LLC · former SEC name · 2013-11-07 to 2013-11-07

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$83.33M$89.50M
2023-12-31$90.24M$99.78M
2022-12-31$112.72M$129.76M
2021-12-31$470.35M$584.76M
2020-12-31$154.57M$201.23M
2019-12-31$35.23M$46.43M
2018-12-31$218.50M$293.18M
2017-12-31$10.39M$14.29M

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗